ArticleAmerican journal of translational research2021

Effect of pemetrexed on the efficacy, toxic reaction, and survival rate of patients with EGFR-TKI resistant moderate and advanced lung cancer.

Pingping Cao et al.PubMed ↗Full text ↗

No numbers read from the abstract.